SlideShare a Scribd company logo
1 of 34
ACUTE RHEUMATIC FEVER
• Multi system disease
• Autoimmune reaction to streptococcal A infection.
• Almost all the manifestations resolve completely.
• Disease of poverty
• M/c age group -5-14 years of age.
• Males= Females.
• Recurrent episodes are more common in young adulta and older
individuals.
• Prevalence of RHD peaks at 25-40 years of age.
• Females> males.
• Group A streptococcal serotypes M- 1,2,4,3,5,6,12,18,24.
• Antibodies to M protein and N-Acetyl glusosamine of GAS.
GENETIC:
Increased susceptibility – HLA-DR7,DR4.
Clinical features:
• Most common cause of acquired valvular heart disease in developing
countries.
• Latent period of 3 weeks(4-5 weeks) except for chorea and indolent
carditis
• M/C clinical features are:
• polyarthritis(60-75%) and carditis(50-60%)
• Chorea-<2-30%.
• Erythemia marginatum and subcutaneous nodules are rare <5%.
• PERICARDIAL DISEASE:
• Acute pericardisits
• Pericardial effusion
• Cardiac tamponade is rare
MYOCARDITIS:
CARDITIS:
• UPTO 60% PATIENTS with ARF progress to RHD.
• endocarditis
• Mitral valve>aortic valve.
• Early valvular damage is regurgitation.
• MR>AR. Pulmonary valve not affected directly.
• Over years- leaflet thickening,scarring,calcification>stenosis.
CLINICAL FEATURES:
• APICAL SYSTOLIC MURMUR
• CAREY COOMBS MURMUR
• AORTIC REGURGITATION MURMUR
• UNEXPALINED HEART FAILURE,PRESENCE OF S3.
• PERICARDIAL FRICTION RUB/ EFFUSION.
TREATMENT
• SUPPORTIVE
• DIURETICS for heart failure.
• If refractory heart failure-trial of steroids and surgery if steroids also
refractory
ARTHRITIS:
• Assymmetrical migratory polyarthritis –n0n erosive with no deformity.
• Duration-<4 weeks.
• Knee,elbow,hip,ankle
• Arthralgia
• Aseptic monoarthritis
• Highly responsive to nsaids,salicylates
CHOREA:
• SYDENHAMS CHOREA:
• Human monoclonal antibodies target gangliosides and target the dopamine
receptors on the surface of the neuron.
• m/c IN FEMALES
• M/C IN head and upper limbs with scooping action.
• Can be isolated as latency is more and other movements have subsided.
• Hypotonia with motor impersistence.(sustained muscle contraction not
maintained)
• ”JACK IN THE BOX”
• MILK MAID GRIP
• Disappear during sleep
• Most common associated with carditis.
TREATMENT:
• Milder cases- Sedation.
• SEVERE CASES- carbamezapine , sodium valproate.
• SEVERE AND REFRACTORY:
CORTICOSTEROIDS,IVIG(as antibody are responsible)
SKIN MANIFESTATIONS:
• Erthema Marginatum-
• MOST SPECIFIC.<10%
• Begins as NON –PRURITIC pink macules –clears centrally-serpigenous
edges.
• Evanescent –Spreads very fast and more prominent after a hot
shower.
• Usually associated with carditis.
• Trunk and limbs more common.Never in the face.
• SUBCUTANEOUS NODULE:’
M/C SITE: Occiput,elbows,knees and Achilles tendon.
Firm,painless and easily movable 0.5-2 cms.
REVISED JONES CRITERIA
• LOW RISK
• <2/100000 SCHOOL GOING
CHILDREN
• INCIDE<1/1000 RHD IN ALL AGE
POPULATION
• HIGH RISK
REVISED JONES CRITERIA:
ESSENTIAL CRITERIA:
• Evidence of recent GAS Throat infection-
• POSITIVE THROAT CULTURE.
• Elevated ASO TITRE ->255 IN Adults.
• Elevated Anti-DNAse.
• CRITERIA FOR DIAGNOSIS:
FIRST EPISODE OF ARF- 2 MAJOR ( OR) 2 MAJOR+1 MINOR.
RECURRENT EPISODE- 2 MAJOR
(OR)
2 MAJOR +1 MINOR
( OR)
3 MINOR
PRIMARY PROPHYLAXIS:
• ARF_ NO CARDITIS
• Antibiotics should be initiated within 9 days of ARF to prevent
progression into carditis.
SECONDARY PREVENTION:
• Decreases the severity of the RHD and regression by 50-70% if strictly
adhered.
TREATMENT OF MAJOR ARF MANIFESATIONS:
THANK YOU

More Related Content

Similar to ACUTE RHEUMATIC FEVER.pptx

Rheumatic fever and heart disease
Rheumatic fever and heart diseaseRheumatic fever and heart disease
Rheumatic fever and heart disease
Swapna Pillai
 
leptospirosis
leptospirosisleptospirosis
leptospirosis
Irene Ngu
 
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptxGR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
KelfalaHassanDawoh
 

Similar to ACUTE RHEUMATIC FEVER.pptx (20)

Dermatology 5th year, 5th lecture (Dr. Kazhan)
Dermatology 5th year, 5th lecture (Dr. Kazhan)Dermatology 5th year, 5th lecture (Dr. Kazhan)
Dermatology 5th year, 5th lecture (Dr. Kazhan)
 
SLE -ppt.pptx
SLE -ppt.pptxSLE -ppt.pptx
SLE -ppt.pptx
 
Pars Planitis
Pars PlanitisPars Planitis
Pars Planitis
 
Dermatological emergency
Dermatological emergencyDermatological emergency
Dermatological emergency
 
Sle
SleSle
Sle
 
ACUTE RHEUMATIC FEVER IN THE PAST AND PRESENT
ACUTE RHEUMATIC FEVER IN THE PAST AND PRESENTACUTE RHEUMATIC FEVER IN THE PAST AND PRESENT
ACUTE RHEUMATIC FEVER IN THE PAST AND PRESENT
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Systemic Lupus Erythematosis - SLE -Etiopathogenesis, Clinical features, Adva...
Systemic Lupus Erythematosis - SLE -Etiopathogenesis, Clinical features, Adva...Systemic Lupus Erythematosis - SLE -Etiopathogenesis, Clinical features, Adva...
Systemic Lupus Erythematosis - SLE -Etiopathogenesis, Clinical features, Adva...
 
LOCALISED SCLERODERMA.pptx
LOCALISED SCLERODERMA.pptxLOCALISED SCLERODERMA.pptx
LOCALISED SCLERODERMA.pptx
 
Systemic Sclerosis 2017
Systemic Sclerosis 2017Systemic Sclerosis 2017
Systemic Sclerosis 2017
 
Acute rheumatic fever
Acute rheumatic feverAcute rheumatic fever
Acute rheumatic fever
 
Rheumatic fever and heart disease
Rheumatic fever and heart diseaseRheumatic fever and heart disease
Rheumatic fever and heart disease
 
leptospirosis
leptospirosisleptospirosis
leptospirosis
 
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptxGR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
 
Rosacea tutorial.pptx
Rosacea tutorial.pptxRosacea tutorial.pptx
Rosacea tutorial.pptx
 
Rosacea tutorial.pptx
Rosacea tutorial.pptxRosacea tutorial.pptx
Rosacea tutorial.pptx
 
Rheumatic heart disease
Rheumatic heart disease Rheumatic heart disease
Rheumatic heart disease
 
Multiple Sclerosis
Multiple SclerosisMultiple Sclerosis
Multiple Sclerosis
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Connective Tissue Disorders.pptx
Connective Tissue Disorders.pptxConnective Tissue Disorders.pptx
Connective Tissue Disorders.pptx
 

More from ssuser942c99 (7)

CARDOMYOPATHY FINAL.pptx
CARDOMYOPATHY FINAL.pptxCARDOMYOPATHY FINAL.pptx
CARDOMYOPATHY FINAL.pptx
 
Burns-Original.pptx
Burns-Original.pptxBurns-Original.pptx
Burns-Original.pptx
 
BIOFILMS 2.pptx
BIOFILMS 2.pptxBIOFILMS 2.pptx
BIOFILMS 2.pptx
 
LIPOSUCTION DR.CHN.pptx
LIPOSUCTION DR.CHN.pptxLIPOSUCTION DR.CHN.pptx
LIPOSUCTION DR.CHN.pptx
 
CME –JULY 2023 - WORK PLAN.pptx
CME –JULY 2023 - WORK PLAN.pptxCME –JULY 2023 - WORK PLAN.pptx
CME –JULY 2023 - WORK PLAN.pptx
 
Instrument - liposuction.pptx
Instrument - liposuction.pptxInstrument - liposuction.pptx
Instrument - liposuction.pptx
 
cartilage graft and healing.pptx
cartilage graft and healing.pptxcartilage graft and healing.pptx
cartilage graft and healing.pptx
 

Recently uploaded

Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
JRRolfNeuqelet
 

Recently uploaded (20)

Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 

ACUTE RHEUMATIC FEVER.pptx

  • 2.
  • 3.
  • 4. • Multi system disease • Autoimmune reaction to streptococcal A infection. • Almost all the manifestations resolve completely. • Disease of poverty • M/c age group -5-14 years of age. • Males= Females. • Recurrent episodes are more common in young adulta and older individuals. • Prevalence of RHD peaks at 25-40 years of age. • Females> males.
  • 5.
  • 6. • Group A streptococcal serotypes M- 1,2,4,3,5,6,12,18,24. • Antibodies to M protein and N-Acetyl glusosamine of GAS. GENETIC: Increased susceptibility – HLA-DR7,DR4.
  • 7.
  • 8.
  • 9. Clinical features: • Most common cause of acquired valvular heart disease in developing countries. • Latent period of 3 weeks(4-5 weeks) except for chorea and indolent carditis • M/C clinical features are: • polyarthritis(60-75%) and carditis(50-60%) • Chorea-<2-30%. • Erythemia marginatum and subcutaneous nodules are rare <5%.
  • 10. • PERICARDIAL DISEASE: • Acute pericardisits • Pericardial effusion • Cardiac tamponade is rare
  • 12.
  • 13. CARDITIS: • UPTO 60% PATIENTS with ARF progress to RHD. • endocarditis • Mitral valve>aortic valve. • Early valvular damage is regurgitation. • MR>AR. Pulmonary valve not affected directly. • Over years- leaflet thickening,scarring,calcification>stenosis.
  • 14.
  • 15. CLINICAL FEATURES: • APICAL SYSTOLIC MURMUR • CAREY COOMBS MURMUR • AORTIC REGURGITATION MURMUR • UNEXPALINED HEART FAILURE,PRESENCE OF S3. • PERICARDIAL FRICTION RUB/ EFFUSION.
  • 16. TREATMENT • SUPPORTIVE • DIURETICS for heart failure. • If refractory heart failure-trial of steroids and surgery if steroids also refractory
  • 17. ARTHRITIS: • Assymmetrical migratory polyarthritis –n0n erosive with no deformity. • Duration-<4 weeks. • Knee,elbow,hip,ankle • Arthralgia • Aseptic monoarthritis • Highly responsive to nsaids,salicylates
  • 18.
  • 19. CHOREA: • SYDENHAMS CHOREA: • Human monoclonal antibodies target gangliosides and target the dopamine receptors on the surface of the neuron. • m/c IN FEMALES • M/C IN head and upper limbs with scooping action. • Can be isolated as latency is more and other movements have subsided. • Hypotonia with motor impersistence.(sustained muscle contraction not maintained) • ”JACK IN THE BOX” • MILK MAID GRIP • Disappear during sleep • Most common associated with carditis.
  • 20.
  • 21. TREATMENT: • Milder cases- Sedation. • SEVERE CASES- carbamezapine , sodium valproate. • SEVERE AND REFRACTORY: CORTICOSTEROIDS,IVIG(as antibody are responsible)
  • 22. SKIN MANIFESTATIONS: • Erthema Marginatum- • MOST SPECIFIC.<10% • Begins as NON –PRURITIC pink macules –clears centrally-serpigenous edges. • Evanescent –Spreads very fast and more prominent after a hot shower. • Usually associated with carditis. • Trunk and limbs more common.Never in the face.
  • 23. • SUBCUTANEOUS NODULE:’ M/C SITE: Occiput,elbows,knees and Achilles tendon. Firm,painless and easily movable 0.5-2 cms.
  • 24. REVISED JONES CRITERIA • LOW RISK • <2/100000 SCHOOL GOING CHILDREN • INCIDE<1/1000 RHD IN ALL AGE POPULATION • HIGH RISK
  • 25.
  • 27. ESSENTIAL CRITERIA: • Evidence of recent GAS Throat infection- • POSITIVE THROAT CULTURE. • Elevated ASO TITRE ->255 IN Adults. • Elevated Anti-DNAse. • CRITERIA FOR DIAGNOSIS: FIRST EPISODE OF ARF- 2 MAJOR ( OR) 2 MAJOR+1 MINOR. RECURRENT EPISODE- 2 MAJOR (OR) 2 MAJOR +1 MINOR ( OR) 3 MINOR
  • 28. PRIMARY PROPHYLAXIS: • ARF_ NO CARDITIS • Antibiotics should be initiated within 9 days of ARF to prevent progression into carditis.
  • 29.
  • 30.
  • 31. SECONDARY PREVENTION: • Decreases the severity of the RHD and regression by 50-70% if strictly adhered.
  • 32.
  • 33. TREATMENT OF MAJOR ARF MANIFESATIONS: